Release Date: 23/08/11 13:37 Summary: 2009 Annual Report to shareholders Price Sensitive: No Download Document 505.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%